EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Association of IgA antiphospholipid antibodies with hypercoagulability and inflammation in antiphospholipid syndrome

Isabella Constantini Soares de Andrade, Luísa Reis Figueiredo Pinto, Silmara Aparecida de Lima Montalvão, Marina Pereira Colella, Gabriela Goés Yamaguti-Hayakawa, Joyce Maria Annichino-Bizzacchi, Erich Vinícius De Paula, Fernanda Andrade Orsi

Journal of Thrombosis and Thrombolysis · 18.05.2026 · 59 (6) · 1644-1653

DOI: 10.1007/s11239-026-03316-1 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Thrombosis and Thrombolysis, online erschienen am 18.05.2026. Verfasst von Isabella Constantini Soares de Andrade und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Hemotherapy Center, University of Campinas (UNICAMP), Campinas, Brazil. Hauptthemen laut MEDLINE: Antibodies, Antiphospholipid, Antiphospholipid Syndrome, Immunoglobulin A, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Estadual De Campinas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although IgA isotype testing does not enhance diagnostic accuracy of antiphospholipid syndrome (APS), recent studies suggest that IgA aCL/aβ2GPI are associated with systemic lupus erythematosus (SLE) and thrombosis, contributing to thromboinflammatory responses and potentially serving as prognostic markers. This study’s objective is to determine whether IgA aCL/aβ2GPI are associated with coagulation and inflammatory responses, as well as a high-risk thrombotic APS (t-APS) profile. A total of 81 patients with t-APS were included. IgA aCL and IgA aβ2GPI were measured using chemiluminescence. Coagulation and inflammatory markers (TNF-α, IL-6, IL-8, IFN-α, TF, VWF, ADAMTS13) were measured by ELISA, and then, their levels and activity compared between IgA-positive and negative patients. The association of IgA and relevant outcomes (antiphospholipid [aPL] profile, recurrent thrombosis, SLE), was assessed by logistic models adjusted for age and sex. IgA aCL or aβ2GPI positivity was observed in 24 patients (29.6%), mostly with both antibodies ( n = 23). IgA positivity was not associated with demographics, comorbidities or pregnancy complications, but correlated with triple aPL positivity (48% vs. 13%, P = 0.004) and higher risk of progression to SLE (17% vs. 0%, P = 0.004). IgA-positive patients showed significantly elevated TNF-α, IL-8, and TF levels ( P = 0.03, P = 0.03 and P = 0.05, respectively). In conclusion, IgA aCL/aβ2GPI positivity is associated with triple aPL positivity, progression to SLE, and altered thromboinflammatory markers, thus highlighting their association with a pronounced thromboinflammatory APS profile. This emphasizes the association of IgA antibodies with a high-risk serological profile and the potential utility of IgA testing in APS. Clinical trial registration: This study is not a clinical trial that requires registration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, AntiphospholipidAntiphospholipid SyndromeImmunoglobulin AInflammationThrombophiliaAdultFemaleHumansMaleMiddle AgedBiomarkersThrombosis

Stichwörter der Autor:innen

Antiphospholipid antibodiesAntiphospholipid syndromeIgA antibodyInflammationThrombosis

Substanzen

Antibodies, AntiphospholipidBiomarkersImmunoglobulin A

Autor:innen und Institutionen

  • Hematology and Hemotherapy Center, University of Campinas (UNICAMP), Campinas, Brazil.
  • School of Medical Sciences, University of Campinas (UNICAMP), Rua Tessália Vieira de Camargo, 126 - Cidade Universitária, Campinas, 13083-887, SP, Brazil.
  • Hematology and Hemotherapy Center, University of Campinas (UNICAMP), Campinas, Brazil. ferorsi@unicamp.br.
  • School of Medical Sciences, University of Campinas (UNICAMP), Rua Tessália Vieira de Camargo, 126 - Cidade Universitária, Campinas, 13083-887, SP, Brazil. ferorsi@unicamp.br.

Förderung

  • Universidade Estadual De Campinas

Zitieren

APA

de Andrade, I. C. S., Pinto, L. R. F., Montalvão, S. A. L., Colella, M. P., Yamaguti-Hayakawa, G. G., Annichino-Bizzacchi, J. M., De Paula, E. V., & Orsi, F. A. (2026). Association of IgA antiphospholipid antibodies with hypercoagulability and inflammation in antiphospholipid syndrome. Journal of Thrombosis and Thrombolysis, 59(6), 1644-1653. https://doi.org/10.1007/s11239-026-03316-1

Vancouver

de Andrade ICS, Pinto LRF, Montalvão SAL, Colella MP, Yamaguti-Hayakawa GG, Annichino-Bizzacchi JM, et al. Association of IgA antiphospholipid antibodies with hypercoagulability and inflammation in antiphospholipid syndrome. Journal of Thrombosis and Thrombolysis. 2026;59(6):1644-1653. doi:10.1007/s11239-026-03316-1

BibTeX
@article{deAndrade2026,
  author = {de Andrade, Isabella Constantini Soares and Pinto, Luísa Reis Figueiredo and Montalvão, Silmara Aparecida de Lima and Colella, Marina Pereira and Yamaguti-Hayakawa, Gabriela Goés and Annichino-Bizzacchi, Joyce Maria and De Paula, Erich Vinícius and Orsi, Fernanda Andrade},
  title = {Association of IgA antiphospholipid antibodies with hypercoagulability and inflammation in antiphospholipid syndrome},
  journal = {Journal of Thrombosis and Thrombolysis},
  year = {2026},
  volume = {59},
  number = {6},
  pages = {1644--1653},
  doi = {10.1007/s11239-026-03316-1}
}
Kostenlos starten →